Cargando…

Evaluation of catastrophic health expenditure risk due to measles in Nigeria

Measles can have a substantial negative impact not only on people’s health but also on their finances, especially in developing countries. This study evaluates the household risk of catastrophic health expenditure (CHE) due to measles, according to regions and wealth quintiles. The CHE risk due to m...

Descripción completa

Detalles Bibliográficos
Autor principal: Sato, Ryoko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302492/
https://www.ncbi.nlm.nih.gov/pubmed/35483039
http://dx.doi.org/10.1080/21645515.2022.2065836
_version_ 1784751643761311744
author Sato, Ryoko
author_facet Sato, Ryoko
author_sort Sato, Ryoko
collection PubMed
description Measles can have a substantial negative impact not only on people’s health but also on their finances, especially in developing countries. This study evaluates the household risk of catastrophic health expenditure (CHE) due to measles, according to regions and wealth quintiles. The CHE risk due to measles was computed based on (1) the likelihood of health service utilization to treat measles, (2) out-of-pocket (OOP) expenditure and indirect costs associated with disease treatment, and (3) household consumption expenditures. I derived the CHE risk associated with measles, conditional on contracting the disease, across regions and wealth quintiles in Nigeria, using secondary data sources for health-care utilization, OOP expenditures, and consumption expenditures. There was a large variation in CHE risk according to regions and wealth quintiles. Among the poorest households, those in the northeast and northwest would have the highest risk of CHE, up to 17%, while those in the southwest would have the lowest risk of 5%. For all regions, as the wealth increases, the CHE risk would decrease. There would be zero or very little CHE risk among the richest households in any regions. Given the proven efficacy of measles vaccines, immunizations can prevent households, especially poorer households in northeast and northwest regions, from facing the CHE risk due to measles.
format Online
Article
Text
id pubmed-9302492
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-93024922022-07-22 Evaluation of catastrophic health expenditure risk due to measles in Nigeria Sato, Ryoko Hum Vaccin Immunother Licensed Vaccines – Research Paper Measles can have a substantial negative impact not only on people’s health but also on their finances, especially in developing countries. This study evaluates the household risk of catastrophic health expenditure (CHE) due to measles, according to regions and wealth quintiles. The CHE risk due to measles was computed based on (1) the likelihood of health service utilization to treat measles, (2) out-of-pocket (OOP) expenditure and indirect costs associated with disease treatment, and (3) household consumption expenditures. I derived the CHE risk associated with measles, conditional on contracting the disease, across regions and wealth quintiles in Nigeria, using secondary data sources for health-care utilization, OOP expenditures, and consumption expenditures. There was a large variation in CHE risk according to regions and wealth quintiles. Among the poorest households, those in the northeast and northwest would have the highest risk of CHE, up to 17%, while those in the southwest would have the lowest risk of 5%. For all regions, as the wealth increases, the CHE risk would decrease. There would be zero or very little CHE risk among the richest households in any regions. Given the proven efficacy of measles vaccines, immunizations can prevent households, especially poorer households in northeast and northwest regions, from facing the CHE risk due to measles. Taylor & Francis 2022-04-28 /pmc/articles/PMC9302492/ /pubmed/35483039 http://dx.doi.org/10.1080/21645515.2022.2065836 Text en © 2022 The Author(s). Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
spellingShingle Licensed Vaccines – Research Paper
Sato, Ryoko
Evaluation of catastrophic health expenditure risk due to measles in Nigeria
title Evaluation of catastrophic health expenditure risk due to measles in Nigeria
title_full Evaluation of catastrophic health expenditure risk due to measles in Nigeria
title_fullStr Evaluation of catastrophic health expenditure risk due to measles in Nigeria
title_full_unstemmed Evaluation of catastrophic health expenditure risk due to measles in Nigeria
title_short Evaluation of catastrophic health expenditure risk due to measles in Nigeria
title_sort evaluation of catastrophic health expenditure risk due to measles in nigeria
topic Licensed Vaccines – Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302492/
https://www.ncbi.nlm.nih.gov/pubmed/35483039
http://dx.doi.org/10.1080/21645515.2022.2065836
work_keys_str_mv AT satoryoko evaluationofcatastrophichealthexpenditureriskduetomeaslesinnigeria